​

Bruker (BRKR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BRKR Stock Forecast

Bruker (BRKR) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $52.13, with a high of $60.00 and a low of $35.00. This represents a 47.51% increase from the last price of $35.34.

$35 $47 $59 $71 $83 $95 High: $60 Avg: $52.13 Low: $35 Last Closed Price: $35.34

BRKR Stock Rating

Bruker stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (50.00%), 14 Hold (43.75%), 2 Sell (6.25%), and 0 Strong Sell (0.00%).

Buy
Total 32 0 2 14 16 Strong Sell Sell Hold Buy Strong Buy

BRKR Price Target Upside V Benchmarks

TypeNameUpside
StockBruker47.51%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks31.84%

Price Target Trends

1M3M12M
# Anlaysts-617
Avg Price Target-$49.17$49.18
Last Closing Price$35.34$35.34$35.34
Upside/Downside-39.13%39.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 262751-15
Feb, 262751-15
Jan, 262751-15
Dec, 25256--13
Nov, 25256--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 13, 2026Evie KosloskyGoldman Sachs$35.00$37.19-5.89%-0.96%
Feb 13, 2026UBS$49.00$36.9932.47%38.65%
Feb 13, 2026Luke SergottBarclays$50.00$37.5133.30%41.48%
Feb 12, 2026Jefferies$50.00$37.5133.30%41.48%
Jan 26, 2026Guggenheim$58.00$49.0318.29%64.12%
Jan 05, 2026Subbu NambiGuggenheim$53.00$49.876.28%49.97%
Dec 15, 2025Brandon CouillardWells Fargo$55.00$45.1321.87%55.63%
Dec 15, 2025Barclays$55.00$45.1321.87%55.63%
Dec 10, 2025Wolfe Research$60.00$47.6525.92%69.78%
Dec 09, 2025Goldman Sachs$40.00$46.00-13.04%13.19%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 13, 2026Goldman SachsSellSellhold
Feb 13, 2026UBSNeutralNeutralhold
Feb 13, 2026CitigroupNeutralNeutralhold
Feb 13, 2026BarclaysOverweightOverweighthold
Jan 26, 2026GuggenheimBuyBuyhold
Jan 16, 2026CitigroupNeutralNeutralhold
Jan 07, 2026Cowen & Co.HoldHoldhold
Jan 05, 2026GuggenheimBuyBuyhold
Dec 15, 2025Wells FargoOverweightOverweighthold
Dec 15, 2025BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.83$2.00$2.92$0.76$-0.15---
Avg Forecast$2.09$2.32$2.55$2.39$2.68$3.04$3.49$3.76
High Forecast$2.12$2.33$2.58$2.40$2.73$3.08$3.55$3.82
Low Forecast$2.06$2.30$2.52$2.38$2.59$2.97$3.41$3.68
Surprise %-12.44%-13.79%14.51%-68.20%-105.60%---

Revenue Forecast

$2B $3B $3B $4B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.42B$2.53B$2.96B$3.37B$3.44B---
Avg Forecast$2.40B$2.50B$2.92B$3.35B$3.56B$3.76B$4.02B$4.19B
High Forecast$2.42B$2.51B$2.95B$3.39B$3.59B$3.78B$4.02B$4.23B
Low Forecast$2.37B$2.48B$2.87B$3.34B$3.54B$3.75B$4.02B$4.11B
Surprise %0.83%1.20%1.66%0.40%-3.48%---

Net Income Forecast

$-50M $80M $210M $340M $470M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$277.10M$296.60M$427.20M$113.10M$-8.60M---
Avg Forecast$215.24M$241.59M$427.20M$351.43M$391.14M$445.47M$512.28M$553.96M
High Forecast$258.29M$289.91M$512.64M$352.90M$401.21M$453.91M$521.99M$562.22M
Low Forecast$172.19M$193.27M$341.76M$349.97M$381.08M$437.03M$502.58M$541.32M
Surprise %28.74%22.77%--67.82%-102.20%---

BRKR Forecast FAQ

Is Bruker stock a buy?

Bruker stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 14 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Bruker is a favorable investment for most analysts.

What is Bruker's price target?

Bruker's price target, set by 32 Wall Street analysts, averages $52.13 over the next 12 months. The price target range spans from $35 at the low end to $60 at the high end, suggesting a potential 47.51% change from the previous closing price of $35.34.

How does Bruker stock forecast compare to its benchmarks?

Bruker's stock forecast shows a 47.51% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (31.84%).

What is the breakdown of analyst ratings for Bruker over the past three months?

  • March 2026: 13.33% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 0% Strong Sell.
  • February 2026: 13.33% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 0% Strong Sell.
  • January 2026: 13.33% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 0% Strong Sell.

What is Bruker’s EPS forecast?

Bruker's average annual EPS forecast for its fiscal year ending in December 2026 is $3.04, marking a -2126.67% decrease from the reported $-0.15 in 2025. Estimates for the following years are $3.49 in 2027, and $3.76 in 2028.

What is Bruker’s revenue forecast?

Bruker's average annual revenue forecast for its fiscal year ending in December 2026 is $3.76B, reflecting a 9.49% increase from the reported $3.44B in 2025. The forecast for 2027 is $4.02B, and $4.19B for 2028.

What is Bruker’s net income forecast?

Bruker's net income forecast for the fiscal year ending in December 2026 stands at $445.47M, representing a -5279.87% decrease from the reported $-8.6M in 2025. Projections indicate $512.28M in 2027, and $553.96M in 2028.